Definium Therapeutics, Inc. (DFTX)
34.18
-0.91
(-2.59%)
USD |
NASDAQ |
Oct 08, 16:00
34.49
+0.31
(+0.91%)
After-Hours: 20:00
Definium Therapeutics Price to Book Value : 4.999 for Oct. 8, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 08, 2026 | 4.999 |
| October 07, 2026 | 5.132 |
| October 06, 2026 | 5.210 |
| October 05, 2026 | 5.299 |
| October 02, 2026 | 5.470 |
| October 01, 2026 | 5.499 |
| September 30, 2026 | 5.567 |
| September 29, 2026 | 5.589 |
| September 28, 2026 | 5.618 |
| September 25, 2026 | 5.290 |
| September 24, 2026 | 5.372 |
| September 23, 2026 | 5.507 |
| September 22, 2026 | 5.897 |
| September 21, 2026 | 5.745 |
| September 18, 2026 | 5.676 |
| September 17, 2026 | 5.657 |
| September 16, 2026 | 5.536 |
| September 15, 2026 | 5.385 |
| September 14, 2026 | 5.887 |
| September 11, 2026 | 5.688 |
| September 10, 2026 | 5.518 |
| September 09, 2026 | 5.556 |
| September 08, 2026 | 5.592 |
| September 04, 2026 | 5.571 |
| September 03, 2026 | 5.558 |
| Date | Value |
|---|---|
| September 02, 2026 | 5.690 |
| September 01, 2026 | 5.631 |
| August 31, 2026 | 5.809 |
| August 28, 2026 | 5.994 |
| August 27, 2026 | 6.409 |
| August 26, 2026 | 6.402 |
| August 25, 2026 | 6.554 |
| August 24, 2026 | 6.329 |
| August 21, 2026 | 6.568 |
| August 20, 2026 | 6.640 |
| August 19, 2026 | 6.702 |
| August 18, 2026 | 6.754 |
| August 17, 2026 | 6.620 |
| August 14, 2026 | 6.235 |
| August 13, 2026 | 6.421 |
| August 12, 2026 | 6.258 |
| August 11, 2026 | 5.984 |
| August 10, 2026 | 6.604 |
| August 07, 2026 | 6.748 |
| August 06, 2026 | 6.748 |
| August 05, 2026 | 6.492 |
| August 04, 2026 | 6.190 |
| August 03, 2026 | 6.112 |
| July 31, 2026 | 6.365 |
| July 30, 2026 | 6.507 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Enliven Therapeutics, Inc. | 3.325 |
| Cocrystal Pharma, Inc. | 14.13 |
| CNBX Pharmaceuticals, Inc. | -- |
| Arvinas, Inc. | 0.8723 |
| Fulcrum Therapeutics, Inc. | 0.9207 |
Price to Book Value Related Metrics
| PEG Ratio | -0.0737 |
| Price | 34.18 |
| Earnings Yield | -10.06% |
| Market Cap | 4.593B |
| PEGY Ratio | -0.0737 |